These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8815955)

  • 1. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice.
    Del Pozo E; Barrios M; Baeyens JM
    Psychopharmacology (Berl); 1996 Jun; 125(3):209-13. PubMed ID: 8815955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice.
    Suzuki T; Kato H; Aoki T; Tsuda M; Narita M; Misawa M
    Life Sci; 2000 Jun; 67(4):383-9. PubMed ID: 11003048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference.
    Zarrindast MR; Lashgari R; Rezayof A; Motamedi F; Nazari-Serenjeh F
    Eur J Pharmacol; 2007 Jul; 568(1-3):192-8. PubMed ID: 17509561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
    Tzschentke TM; Schmidt WJ
    Neurosci Lett; 1995 Jun; 193(1):37-40. PubMed ID: 7566661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced place preference: involvement of the central amygdala NMDA receptors.
    Rezayof A; Golhasani-Keshtan F; Haeri-Rohani A; Zarrindast MR
    Brain Res; 2007 Feb; 1133(1):34-41. PubMed ID: 17184750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization.
    Tzschentke TM; Schmidt WJ
    Behav Brain Res; 1997 Mar; 84(1-2):99-107. PubMed ID: 9079776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y; Asami T; Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain.
    D'Souza DN; Harlan RE; Garcia MM
    Neuroscience; 1999; 93(4):1539-47. PubMed ID: 10501478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NMDA glutamate receptors in the lateral habenula on morphine-induced conditioned place preference in rats.
    Amohashemi E; Reisi P; Alaei H
    Synapse; 2023 Sep; 77(5):30-41. PubMed ID: 37122079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine.
    Sukhotina I; Dravolina O; Bespalov A
    Eur J Pharmacol; 1998 Dec; 362(2-3):103-10. PubMed ID: 9874159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine).
    Ranaldi R; Munn E; Neklesa T; Wise RA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):192-201. PubMed ID: 10972465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of N-methyl-D-aspartate receptors in L-arginine-induced attenuation of morphine antinociception.
    Bhargava HN; Sharma SS; Bian JT
    Brain Res; 1998 Jan; 782(1-2):314-7. PubMed ID: 9519279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain.
    Sufka KJ
    Pain; 1994 Sep; 58(3):355-366. PubMed ID: 7838585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.
    Trujillo KA; Akil H
    Brain Res; 1994 Jan; 633(1-2):178-88. PubMed ID: 8137155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats?
    Vanderschuren LJ; Schoffelmeer AN; De Vries TJ
    Life Sci; 1997; 61(26):PL 427-33. PubMed ID: 9416784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of NMDA receptors in morphine state-dependent learning in mice.
    Zarrindast MR; Jafari-Sabet M; Rezayat M; Djahanguiri B; Rezayof A
    Int J Neurosci; 2006 Jun; 116(6):731-43. PubMed ID: 16753898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of NMDA receptor-ERK pathway in the central amygdala is required for the expression of morphine-conditioned place preference in the rat.
    Li F; Wang XS; Dai RP; Zhang JY; Zhou XF; Hao W; Li CQ
    Neurotox Res; 2011 Nov; 20(4):362-71. PubMed ID: 21681580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.